research

A university research project by the Autonomous University of Barcelona (UAB) has found that married people are healthier than single people. Researchers have proved that marriage has positive effects on the health of people aged 40 and over. The reason for this link between health and marriage is the couple’s role in taking care of each other. In addition, married people are more likely to have health insurance, the study found.The researchers also highlighted that people who are more inclined to marry are innately healthy. In many instances they have particular physical and psychological features, linked to gene quality and good health, which result in them being more attractive and therefore having a greater possibility of getting married. 

In 2011 and 2012, funds for scientific research in Catalonia dropped from €277 million to €224 million, a 19% decrease, according to a study issued on Friday by the Catalan Association of Public Universities. Despite this drastic budget reduction, scientific production has managed to keep similar levels to previous years and continue standing at levels similar to those in countries such as the UK or Belgium. The report compiles the main research and innovation indicators for 2011 and 2012. However, the main representatives of public universities warn that scientific production is at risk and could drop to pre-2010 levels if the budget situation does not shift. They also highlighted that public universities in Catalonia have the challenge of attracting greater private investment for its research projects.

The European Space Agency (ESA) has opened in Catalonia an incubator for businesses working on space technologies, the first of its kind in Spain. It is located in the campus that the Universitat Politècnica de Catalunya (UPC) has in Castelldelfels, a coastal town next to Barcelona El Prat Airport. The incubator is located in the RDIT building of UPC, in what is known as the Energy Campus, and will take up 1,000m2 of space. There are currently four companies installed in the centre, whose operations are centred on "drones" and satellite communication. The project expects to host some 40 companies from now on until 2018. This is the tenth "Business Incubation Centre" that the ESA has opened in Europe so far.

A new computational method allows the detection, within just a few hours, of the genetic alterations responsible for the formation and progression of cancer tumours. This new method manages to accurately identify almost all types of genetic changes of cancer cells in a simple, quick and precise way. It is also able to identify large-scale chromosome rearrangements, which had been difficult to be detect until this breakthrough. The new method, called SMUFIN, has been developed by the Barcelona Supercomputing Centre and the ICREA (Catalan Institution of Research and Advanced Studies), in collaboration with research groups from Barcelona, Oviedo and Heidelberg. This progress has been published by the prestigious journal 'Nature Biotechnology' and represents a significant step forward towards the personalised treatment of cancer and other illnesses.

On Tuesday evening the Barcelona-born opera tenor, Josep Carreras received the Golden Medal of the Catalan Parliament for his outstanding and internationally-recognised professional career, but also for his efforts leading a foundation that fights Leukaemia. In his acceptance speech, Carreras defended Catalonia's right to self-determination and the independence vote scheduled for the 9^th of November. Carreras, who became a true world star in the 1990s with the Three Tenors, praised the idiom "live and let live", meaning that the Spanish authorities should authorise the self-determination vote. He asked the Catalan MPs "to do whatever is necessary to ensure that the others live and let us live". His words were particularly relevant as they were said at such an important event and two days ahead of the massive pro-independence demonstration, which will take place in Barcelona on Catalonia's National Day (the 11^th of September).

During the first half of the year, the revenues of the Catalan multinational pharmaceutical company Grifols rose by 16.7% to €1.61 bilion, 75% of which came from the Bioscience division and 18% from Diagnostic. Compared to the first quarter, the proportion of total sales generated by each of the group’s divisions remains unchanged after the acquisition of Novartis' diagnostic business. The world´s third-largest blood-derivate product maker, Grifols obtained a net profit of €224.8 million, 23% more compared with the same period last year, as reported by the company to the Spanish Stock Exchange Authority (CNMV). These positive figures were achieved due to the maintenance of financial costs, made possible by improved financial conditions, despite having increased debt in absolute terms.

On Wednesday the World Health Organisation (WHO) appointed Barcelona-based researcher Pedro Alonso as the new Director of its Global Malaria Program. Alonso is a key figure in the global fight against malaria and has lead research into a vaccine to combat the life-threatening illness. He has been involved with WHO since 2011, when the organisation appointed him as the Chair of the GTS Steering Committee on the Global Technical Strategy on Malaria. Alonso is currently the Director of the Barcelona Institute for International Health Research. He is also the Head of the Department of International Health and Tropical Medicine at Barcelona's Hospital Clínic and a lecturer at Barcelona University. The physician is due to start his new position in October and is expected to give his formal recommendation on the strategy against malaria in the first quarter of 2015.

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.

An old factory in the 22@ technological and business district of Barcelona, named Ca l'Alier, will be transformed into an innovation centre focused on Smart Cities. The French multinational Schneider Electric and the American networking giant Cisco Systems will invest €6 million in the building's renovation in order to set up their new research centres. The two companies then plan to invest a total of €37 million in the centres over the next 5 years. Barcelona´s City Council will also occupy a part of the renovated building for offices for its new Institute of Technology for the Habitat (BIT Habitat). The renovation of the Ca l'Alier factory will be the first step towards the creation of the Smart City Campus, which will be located throughout the 22@ technological district, a developing business area in Barcelona located around the old Poblenou industrial neighbourhood. The new Ca l'Alier research centres are expected to open in the summer of 2016 and to create 160 jobs.

Barcelona has gone from 22^nd to 7^th place in the list of 468 European cities with the best economic prospects; it is ranked the 19^th most competitive city in the world and the 10^th in Europe; it stands at 10^th in the world in terms of receiving new business investments; and it became the 4^th city hosting the largest amount of congresses at world level. The report was produced by the Chamber of Commerce of Barcelona in collaboration with the City Council. Furthermore, another study compiled by ESADE business school stressed that Barcelona is the 1^st European city in money spent per tourist in shopping, ahead of London and Paris. The Mayor of Barcelona, ??Xavier Trias, welcomed the news but also emphasised the ''shadow'' of having more than 100,000 unemployed in Barcelona, a number he finds “unbearable.”

The Agricultural Science and Technology Park of Lleida (PCiTAL) celebrated its 9th anniversary on Monday, and did so "reaffirming its commitment to the economic future of Lleida", according to the Mayor Àngel Ros. The park hosts some 111 organisations, comprising of 89 companies, 14 research and development centres and 8 research groups. This constitutes five times the number of businesses that were based in the park just five years ago, representing a 540% growth. Significantly, there are more than 1,400 people employed in the park´s facilities, many of them young people. The turnover of the Agricultural Science and Technology Park of Lleida has reached €102.5 million, with an annual growth of 30%.

Researchers from the University of Barcelona (UB) and the Catalan capital’s CELLEX Biomedical Research Centre (IDIBAPS-UB) have found the essential role played by cholesterol in cell mobility and tissue invasion, which also means its role in cancer propagation. In fact, this research, led by Professor Carles Enrich, is a key study for better understanding of cancer metastasis – the process in which cancer cells invade healthy tissues – and progresses the discussion on the relationship between cholesterol levels and cancer incidence. The paper is published in open access ‘Cell Reports’. In short they found that the so-called “bad” cholesterol (LDL cells) promotes cell mobility while “good” cholesterol (HDL cells) avoids cell propagation. The study opens new therapeutic paths to blocking cancer metastasis.

Scientists at the Universitat Autònoma de Barcelona (UAB) have found that an alteration of a neuronal gene program plays an essential role in the first stages of Alzheimer's disease and have developed a gene therapy which is effective on mice. The Catalan study occupies the front page of 'The Journal of Neuroscience'. Researchers have identified a new mechanism that regulates the expression of genes in the brain which are essential for the function of neuronal circuits involved in learning and memory. According to the new study, which was carried out by Dr. Carlos Saura's group at the UAB's Institute of Neurosciences (Institut de Neurociències), the alteration of a gene program mediating neuronal transmission and survival may underlie memory loss at early pathological stages of Alzheimer's disease (AD).

Hewlett-Packard has announced that it will locate its world centre to develop 3D printing business in its facilities at Sant Cugat del Vallès, in Greater Barcelona, where it has already developed part of this technology. In fact, HP's Catalan offices are one of the multinational's main R&D centres at world level. HP also develops the technology for large-format printing in Greater Barcelona, employing some 350 engineers. In addition, it runs its marketing services for Europe, the Middle East and Africa from Catalonia. Now, HP has decided to foster its 3D printing business and Barcelona "will play a significant role", being the group's flagship for the research and development of this technology. HP explained that the main challenges engineers will have to face are the slow speed and low quality of the current 3D printing devices.

Barcelona’s Hospital Clínic has installed the ‘Micra’ 24mm pacemaker - equivalent to the size of a one euro coin -  in 4 patients as part of a clinical trial involving 10 medical centres and 60 patients troughout the world. This innovative wireless system is minimally invasive since it does not require any surgical procedure but is implanted in the heart through the femoral vein using a catheter. Such a procedure can be performed within 30 minutes and also reduces the patients’ risks of future infections. According to the Medical Director of the Hospital, Josep Brugada, if the clinical study is successful, it will involve a “paradigm shift”. Experts estimate it could reach hospitals within the next two or three years.